- Home
- PASG vs NYC Comparison
PASG vs NYC Comparison
Compare PASG & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PASG | NYC |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | 27 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.3M | 23.5M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PASG | NYC |
|---|---|---|
| Price | $9.35 | $8.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $34.50 | N/A |
| AVG Volume (30 Days) | ★ 31.2K | 2.9K |
| Earning Date | 04-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.47 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.40 |
| Revenue Next Year | N/A | $1.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.28 | $7.03 |
| 52 Week High | $20.00 | $16.30 |
Technical Indicators
Market Signals| Indicator | PASG | NYC |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 45.02 |
| Support Level | $6.31 | $7.12 |
| Resistance Level | $10.71 | $10.41 |
| Average True Range (ATR) | 0.99 | 0.43 |
| MACD | 0.00 | -0.09 |
| Stochastic Oscillator | 34.33 | 29.05 |
Price Performance
Historical ComparisonAbout PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.